Company profile: Sancilio & Company
1.1 - Company Overview
Company description
- Provider of biopharmaceutical products and services, including cardiovascular and dental health offerings such as OCEAN BLUE PROFESSIONAL OMEGA-3 2100 and LUDENT; plus startup guidance, compound discovery and synthesis, FDA and EMA-compliant analytical support, dual-facility stability studies, formulation development, and FDA-guideline drug manufacturing across dosage forms.
Products and services
- Drug Manufacturing: Produces drug products according to US FDA guidelines, covering various dosage forms, with processes aligned to regulatory expectations—US FDA-guideline-compliant
- Formulation Development: Crafts tailor-made formulations optimized for efficacy and safety, balancing development facets and manufacturing costs—custom-engineered
- Analytical Support: Delivers drug candidate characterization and method development, ensuring compliance with US FDA and EMA standards for rigorous testing—US FDA/EMA-standard-compliant
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sancilio & Company
Bioject
HQ: United States
Website
- Description: Provider of needle-free injection therapies to improve administration of liquid medications, including pharmaceuticals, vaccines, and biologics, using technology that forces medication at high speed through a tiny orifice held against the skin, with over 25 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioject company profile →
Fertin Pharma
HQ: Denmark
Website
- Description: Provider of innovative, high-quality pharmaceutical and nutraceutical chewing gum products, partnering with leading global pharma companies as a preferred B2B partner for nicotine chewing gum. Offers Zapliq liquefying tablets, compressed and extruded gums (for nicotine replacement therapy and other applications), lozenges, pouch powder, and custom co-developed delivery systems with controlled release.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fertin Pharma company profile →
NuGen Medical Devices
HQ: Canada
Website
- Description: Provider of needle-free medical delivery technologies, including InsuJet, a spring-loaded injection system for self-administration by patients and healthcare practitioners that delivers drugs through the skin, and PetJet, a device for veterinary use facilitating painless, quick treatment for pets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuGen Medical Devices company profile →
Windgap Medical
HQ: United States
Website
- Description: Provider of drug delivery medical devices for severe allergies and other therapeutic areas, including ANDIPen, a wet/dry dual-chamber autoinjector with improved temperature resilience and extended shelf life, and LVDC for large-volume dual-chamber injections of high-viscosity or difficult-to-mix medications with IM and SubQ options. Develops platforms to stabilize heat- and time-sensitive liquids and collaborates with pharmaceutical partners to commercialize its technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Windgap Medical company profile →
Travanti Pharma
HQ: United States
Website
- Description: Provider of innovative drug delivery platforms that improve the safety, compliance, effectiveness, and ease of administration of medications delivered into the body; designs, develops, and markets these platforms to enhance medication delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Travanti Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sancilio & Company
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sancilio & Company
2.2 - Growth funds investing in similar companies to Sancilio & Company
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sancilio & Company
4.2 - Public trading comparable groups for Sancilio & Company
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →